← 產業報告目錄
Radioactive Tracer Market Size, Share & Trends Analysis Report By Tracer Type , Test Type (PET, SPECT, Others), Application (Oncology, Pulmonary, Neurology, Cardiology, Others), End User, Region And Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-12頁數 180報告編號 INSIGHTACE-4ba5ca958f
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The Radioactive Tracer Market on a global scale was estimated at USD 3.5 billion in 2024 and is expected to attain USD 7.19 billion by 2034, with a projected CAGR of 7.4% between 2025 and 2034.
Radioactive Tracer covers The radioactive tracer represents a chemical molecule in which one or more atoms have been replaced with a radionuclide. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space.
Market momentum is driven by mounting need advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, driven by rapid industrialization and expanding end-user bases.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Radioactive Tracer Market Snapshot
Chapter 4. Global Radioactive Tracer Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Tracer Type Estimates & Trend Analysis
5.1. By Tracer Type, & Market Share, 2021 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Tracer Type:
5.2.1. Technetium-99m & Tc-97m
5.2.2. Iodine-131,
5.2.3. Lutetium-171
5.2.4. Rubidium (Rb-82)
5.2.5. Chloride & Ammonia (N-13)
5.2.6. Hassium-269
5.2.7. FDDNP (F-18) & FDOPA (F-18)
5.2.8. Phosphorus-32 & Chromium-51
5.2.9. Thallium-201
5.2.10. F-18
5.2.11. Ga-68 FAPI
5.2.12. Others (Scandium-46, Seaborgium-269)
Chapter 6. Market Segmentation 2: By Test Type Estimates & Trend Analysis
6.1. By Test Type & Market Share, 2021 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Test Type:
6.2.1. PET
6.2.2. SPECT
6.2.3. Others
Chapter 7. Market Segmentation 3: By Application Estimates & Trend Analysis
7.1. By Application & Market Share, 2021 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Application:
7.2.1. Oncology
7.2.2. Pulmonary
7.2.3. Neurology
7.2.4. Cardiology
7.2.5. Others
Chapter 8. Market Segmentation 4: By End-User Estimates & Trend Analysis
8.1. By End-User & Market Share, 2021 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End-User:
8.2.1. Hospitals & Clinics
8.2.2. Diagnostic Centers
8.2.3. Academic & Research Institutes
8.2.4. Others
Chapter 9. Radioactive Tracer Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Radioactive Tracer Market revenue (US$ Million) estimates and forecasts By Tracer Type, 2021-2034
9.1.2. North America Radioactive Tracer Market revenue (US$ Million) estimates and forecasts By Test Type, 2021-2034
9.1.3. North America Radioactive Tracer Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
9.1.4. North America Radioactive Tracer Market revenue (US$ Million) estimates and forecasts By End-User, 2021-2034
9.1.5. North America Radioactive Tracer Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
9.2. Europe
9.2.1. Europe Radioactive Tracer Market revenue (US$ Million) By Tracer Type, 2021-2034
9.2.2. Europe Radioactive Tracer Market revenue (US$ Million) By Test Type, 2021-2034
9.2.3. Europe Radioactive Tracer Market revenue (US$ Million) By Application, 2021-2034
9.2.4. Europe Radioactive Tracer Market revenue (US$ Million) By End-User, 2021-2034
9.2.5. Europe Radioactive Tracer Market revenue (US$ Million) by country, 2021-2034
9.3. Asia Pacific
9.3.1. Asia Pacific Radioactive Tracer Market revenue (US$ Million) By Tracer Type, 2021-2034
9.3.2. Asia Pacific Radioactive Tracer Market revenue (US$ Million) By Test Type, 2021-2034
9.3.3. Asia Pacific Radioactive Tracer Market revenue (US$ Million) By Application, 2021-2034
9.3.4. Asia Pacific Radioactive Tracer Market revenue (US$ Million) By End-User, 2021-2034
9.3.5. Asia Pacific Radioactive Tracer Market revenue (US$ Million) by country, 2021-2034
9.4. Latin America
9.4.1. Latin America Radioactive Tracer Market revenue (US$ Million) By Tracer Type, (US$ Million) 2021-2034
9.4.2. Latin America Radioactive Tracer Market revenue (US$ Million) By Test Type, (US$ Million) 2021-2034
9.4.3. Latin America Radioactive Tracer Market revenue (US$ Million) By Application, (US$ Million) 2021-2034
9.4.4. Latin America Radioactive Tracer Market revenue (US$ Million) By End-User, (US$ Million) 2021-2034
9.4.5. Latin America Radioactive Tracer Market revenue (US$ Million) by country, 2021-2034
9.5. Middle East & Africa
9.5.1. Middle East & Africa Radioactive Tracer Market revenue (US$ Million) By Tracer Type, (US$ Million) 2021-2034
9.5.2. Middle East & Africa Radioactive Tracer Market revenue (US$ Million) By Test Type, (US$ Million) 2021-2034
9.5.3. Middle East & Africa Radioactive Tracer Market revenue (US$ Million) By Application, (US$ Million) 2021-2034
9.5.4. Middle East & Africa Radioactive Tracer Market revenue (US$ Million) By End-User, (US$ Million) 2021-2034
9.5.5. Middle East & Africa Radioactive Tracer Market revenue (US$ Million) by country, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Curium
10.2.2. Telix Pharmaceuticals
10.2.3. Lantheus Holdings, Inc.
10.2.4. GE Healthcare
10.2.5. Life Molecular Imaging
10.2.6. Bracco Imaging
10.2.7. Siemens Healthineers
10.2.8. Cardinal Health
10.2.9. Jubilant Pharmova
10.2.10. Eckert & Ziegler
10.2.11. Avid Radiopharmaceuticals
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們